Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fraction.

Heart failure with preserved ejection fraction adverse outcomes case report hospitalization for heart failure interatrial shunt device long-term follow-up

Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
May 2022
Historique:
entrez: 26 5 2022
pubmed: 27 5 2022
medline: 28 5 2022
Statut: ppublish

Résumé

We herein present a case study of a patient with heart failure with a preserved ejection fraction and severe symptoms who underwent interatrial shunt device implantation and follow-up at a tertiary care heart failure clinic. The interatrial shunt device implantation was successful. No adverse events occurred, and the device prevented hospitalization for heart failure during long-term follow-up.

Identifiants

pubmed: 35615787
doi: 10.1177/03000605221098178
pmc: PMC9152196
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3000605221098178

Références

Eur Heart J. 2013 May;34(19):1404-13
pubmed: 23095984
JAMA Cardiol. 2018 Oct 1;3(10):968-977
pubmed: 30167646
Lancet. 2016 Mar 26;387(10025):1298-304
pubmed: 27025436
Eur J Heart Fail. 2014 Jul;16(7):796-801
pubmed: 24961390
Headache. 2013 Nov-Dec;53(10):1541-7
pubmed: 24266334

Auteurs

Libor Dujka (L)

Cardiology Fellow, Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.

Petr Neužil (P)

Head of Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.

Vivek Reddy (V)

Director of Cardiac Arrhythmia Services for Mount Sinai Hospital and the Mount Sinai Health System, Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, NY 10029, USA.

Martin Mates (M)

Head of CathLab, Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.

Tomáš Mráz (T)

Head of Echocardiography Labs, Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.

Jiří Weichet (J)

Current affiliation: Deputy Chief, Department of Radiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, 100 34, Prague 10, Czech Republic.
Former affiliation: Department of Radiology, Na Homolce Hospital, Roentgenova 2, 150 30, Prague 5, Czech Republic.

Jan Komtebedde (J)

Senior Vice President & Chief Medical Officer, Corvia Medical, Inc., One Highwood Drive, Suite 300, Tewksbury, MA 01876, USA.

Filip Málek (F)

Head of Heart Failure Clinic, Department of Cardiology, Na Homolce Hospital Cardiovascular Center, Roentgenova 2, 150 30, Prague 5, Czech Republic.
Professor of Medicine, Department of Internal Medicine, University Hospital Královské Vinohrady, Third School of Medicine, Charles University, Šrobárova 50, 100 34, Prague 10, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH